• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT. EVA TDC VITRECTOMY PACK VGPC INPUT 25G; SURGICAL PACKS AND KITS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT. EVA TDC VITRECTOMY PACK VGPC INPUT 25G; SURGICAL PACKS AND KITS Back to Search Results
Catalog Number 8310.25G12
Device Problem Material Fragmentation (1261)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/29/2022
Event Type  malfunction  
Event Description
It was reported that during vitrectomy procedure it was noticed that particulate matter was released from vitrectome and entered the eye.The particles were immediately and successfully removed.No patient harm or prolongation of the surgery occurred due to this event.
 
Manufacturer Narrative
The complaint is under investigation.
 
Manufacturer Narrative
In regard to this complaint, one 25 gauge disposable high speed tdc cutter was returned for investigation.The particle that was detected in the eye of the patient was not received.Since the particle was not received, inspection and testing to determine its origin were not possible.Thorough examination of the cutter revealed no anomalies; the cap at the distal end of the outer knife as well as the bridge and welds of the inner knife appeared to be completely intact.Device history record review revealed no deviations and a database search showed that no similar complaints have been reported on this specific lot previously.Based on the investigation performed, the origin of the particle could not be determined.The particle may have originated from any (metal) instrument that was used during the operation, but we cannot exclude the possibility that it did in fact originate from the cutter.Hence, the investigation findings did not lead to a clear conclusion concerning the cause of the reported adverse event.The risk identified is included in the risk management documentation.Trend analysis indicates that the product is performing within anticipated rates.Complaints will be closely monitored to identify any significant adverse trends.Since the reported adverse event cannot be attributed to the dorc cutter, further remedial/corrective/fsc actions are deemed not required.
 
Event Description
It was reported that during vitrectomy procedure it was noticed that particulate matter was released from vitrectome and entered the eye.The particals were immediately and successfully removed.No patient harm or prolongation of the surgery occurred due to this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVA TDC VITRECTOMY PACK VGPC INPUT 25G
Type of Device
SURGICAL PACKS AND KITS
Manufacturer (Section D)
D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.
scheijdelveweg 2
zuidland, 3214 VN
NL  3214 VN
Manufacturer (Section G)
D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER INT.
scheijdelveweg 2
zuidland, 3214 VN
NL   3214 VN
Manufacturer Contact
danielle sleegers
scheijdelveweg 2
zuidland, 3214 -VN
NL   3214 VN
MDR Report Key14100938
MDR Text Key290063712
Report Number1222074-2022-00030
Device Sequence Number1
Product Code HQC
Combination Product (y/n)N
Reporter Country CodeSP
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 05/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/13/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number8310.25G12
Device Lot Number2000429590
Is the Reporter a Health Professional? No
Was Device Evaluated by Manufacturer? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-